Micronucleus Assay in Urothelial Cells in Cancer Cervix

Introduction: Cancer ranks third among the ten leading global causes of death. To evaluate the genotoxic risks, observed as DNA damages, can be assessed by Micronucleus (MN) test. Aim: To identify the occurrence of MN in normal and cancer cervix and find the correlation between MN and stage of...

Full description

Bibliographic Details
Main Authors: Suresh Kumar Sundararajan, Pratheepa Sivasankari Natarajan, Kanchana
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/9488/23425_CE[Ra1]_F(RK)_PF1(SYGH)_PFA(GH)_PF2(NE_SY_DK).pdf
_version_ 1818531400394997760
author Suresh Kumar Sundararajan
Pratheepa Sivasankari Natarajan
Kanchana
author_facet Suresh Kumar Sundararajan
Pratheepa Sivasankari Natarajan
Kanchana
author_sort Suresh Kumar Sundararajan
collection DOAJ
description Introduction: Cancer ranks third among the ten leading global causes of death. To evaluate the genotoxic risks, observed as DNA damages, can be assessed by Micronucleus (MN) test. Aim: To identify the occurrence of MN in normal and cancer cervix and find the correlation between MN and stage of cancer. Materials and Methods: A total of 60 females were included in the study and visual examination of the cervix was done. Based on the examination two groups were formed: A- Normal cervix (n-23) and B- Presence of erosion or growth or ulcer etc., in cervix (n-37). Midstream urine sample was collected and centrifuged from the cases after getting the informed consent. Slides were prepared from the pellet, were fixed in methanol, glacial acetic acid fixative and stained with Giemsa and May Grunwald stain. Statistical analysis was done by student’s t-test and chi-square test. Results: A linear association was noted between the mean MN count and cancer cervix stage. Almost 18.2% of the Group A cases had significant MN count. Sensitivity and specificity of MN count in Group A was 83.8% and 82.6% respectively. The efficiency was 83.3%. Conclusion: A statistically significant MN count was seen in the different stages of cancer cervix. There are cases who had normal findings on visual inspection of cervix but with significant MN count are prone for malignant transformation. MN assay is an easy, non-invasive, cost-effective method and can be used as a screening test for a large population.
first_indexed 2024-12-11T17:31:59Z
format Article
id doaj.art-145194df5bf94d2bb601cf2586cc1227
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-11T17:31:59Z
publishDate 2017-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-145194df5bf94d2bb601cf2586cc12272022-12-22T00:56:47ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2017-03-01113XC01XC0310.7860/JCDR/2017/23425.9488Micronucleus Assay in Urothelial Cells in Cancer CervixSuresh Kumar Sundararajan0Pratheepa Sivasankari Natarajan1Kanchana2Assistant Professor, Department of Medical Oncology, Madras Medical College and Hospital, Chennai, Tamil Nadu, India.Associate Professor, Department of Anatomy, SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu, India.Professor, Department of Pathology, Madras Medical College and Hospital, Chennai, Tamil Nadu, India.Introduction: Cancer ranks third among the ten leading global causes of death. To evaluate the genotoxic risks, observed as DNA damages, can be assessed by Micronucleus (MN) test. Aim: To identify the occurrence of MN in normal and cancer cervix and find the correlation between MN and stage of cancer. Materials and Methods: A total of 60 females were included in the study and visual examination of the cervix was done. Based on the examination two groups were formed: A- Normal cervix (n-23) and B- Presence of erosion or growth or ulcer etc., in cervix (n-37). Midstream urine sample was collected and centrifuged from the cases after getting the informed consent. Slides were prepared from the pellet, were fixed in methanol, glacial acetic acid fixative and stained with Giemsa and May Grunwald stain. Statistical analysis was done by student’s t-test and chi-square test. Results: A linear association was noted between the mean MN count and cancer cervix stage. Almost 18.2% of the Group A cases had significant MN count. Sensitivity and specificity of MN count in Group A was 83.8% and 82.6% respectively. The efficiency was 83.3%. Conclusion: A statistically significant MN count was seen in the different stages of cancer cervix. There are cases who had normal findings on visual inspection of cervix but with significant MN count are prone for malignant transformation. MN assay is an easy, non-invasive, cost-effective method and can be used as a screening test for a large population.https://jcdr.net/articles/PDF/9488/23425_CE[Ra1]_F(RK)_PF1(SYGH)_PFA(GH)_PF2(NE_SY_DK).pdfcervical malignancygenotoxicitynuclear abnormalities
spellingShingle Suresh Kumar Sundararajan
Pratheepa Sivasankari Natarajan
Kanchana
Micronucleus Assay in Urothelial Cells in Cancer Cervix
Journal of Clinical and Diagnostic Research
cervical malignancy
genotoxicity
nuclear abnormalities
title Micronucleus Assay in Urothelial Cells in Cancer Cervix
title_full Micronucleus Assay in Urothelial Cells in Cancer Cervix
title_fullStr Micronucleus Assay in Urothelial Cells in Cancer Cervix
title_full_unstemmed Micronucleus Assay in Urothelial Cells in Cancer Cervix
title_short Micronucleus Assay in Urothelial Cells in Cancer Cervix
title_sort micronucleus assay in urothelial cells in cancer cervix
topic cervical malignancy
genotoxicity
nuclear abnormalities
url https://jcdr.net/articles/PDF/9488/23425_CE[Ra1]_F(RK)_PF1(SYGH)_PFA(GH)_PF2(NE_SY_DK).pdf
work_keys_str_mv AT sureshkumarsundararajan micronucleusassayinurothelialcellsincancercervix
AT pratheepasivasankarinatarajan micronucleusassayinurothelialcellsincancercervix
AT kanchana micronucleusassayinurothelialcellsincancercervix